Slamming the heavy lab door shut, Julian faced Clara across a sterile expanse of chrome and humming machinery. The air crackled with unspoken tension, thick and suffocating. Leo's critical condition hung between them, a shared, agonizing burden. "We need to move now," Julian snapped, his voice rough. Every muscle in his jaw was taut. "Show me the full protocol. Every detail." Clara didn't flinch. Her expression was meticulously neutral, a stark contrast to the storm in his eyes. She moved with practiced efficiency to a large display screen, her fingers flying across a holographic keyboard. "The gene-editing sequence is highly complex," she began, her tone purely professional. "It targets the specific genetic markers causing the accelerated cellular decay. The viral vector is engineered for minimal immunogenicity." Julian leaned closer to the screen, his gaze dissecting the intricate schematics. Numbers, diagrams, and molecular structures flashed across the display. He was looking for any loophole, any potential flaw. "Explain the delivery mechanism," he demanded, his finger jabbing at a complex diagram. "And the potential for off-target edits." Precise and unwavering, Clara elaborated. "We're using an AAV vector, serotype 9, optimized for CNS penetration. The CRISPR-Cas9 system is guided by a dual sgRNA approach, significantly reducing off-target risks to below 0.01%." His brow furrowed. He knew the data. He knew the theory. It was cutting-edge, terrifyingly so. "What about dosage? The systemic impact?" Julian pressed, his voice edged with a desperate urgency. Leo's fragile body couldn't withstand any more trauma. "Initial trials in preclinical models showed no significant systemic toxicity at the therapeutic dose," Clara responded, scrolling through pages of data. "We'll start with a conservative dose and monitor Leo's biomarkers closely. The half-life of the viral vector allows for a window of adjustment if necessary." Julian paced, the sterile linoleum floor cold beneath his expensive shoes. Each word Clara uttered was a tiny thread of hope, but also a potential noose. He hated that he had to rely on her. Watching her, Julian felt a flicker of grudging acknowledgment. Her explanations were clear, concise, and incredibly detailed. She wasn't just reciting facts; she understood the underlying science intimately. "The primary challenge," Clara continued, her eyes fixed on the data, "is the rapid progression of Leo's condition. The cellular degradation is accelerating. We're fighting against time for effective integration and expression of the corrective gene." A cold dread settled in Julian's stomach. Time. The enemy he could never beat. "What are the immediate post-treatment risks?" he asked, forcing the words out. He had to know the worst-case scenario. Clara turned to face him fully, her gaze meeting his without wavering. "Acute inflammatory response, cytokine storm, potential neurological side effects if the vector crosses the blood-brain barrier unexpectedly, although our data suggests high specificity. And, of course, the primary risk of non-efficacy." Her voice was devoid of emotion, a clinical recitation of horrors. Yet, the stark honesty in her assessment resonated with his own medical training. She wasn't sugarcoating anything. Julian ran a hand through his hair, his frustration a palpable force in the room. "And the success rate? In patients like Leo?" "There are no patients exactly like Leo," Clara stated simply, her voice low. "This specific mutation, with this rapid onset… he is unique. This treatment is our best, perhaps only, option." That simple truth hit him hard. He was a doctor, a man of science, and yet, he was grasping at straws, trusting the woman he despised with his son's life. It was an unbearable irony. "Let's review the genetic sequencing data again," Julian commanded, stepping back to the screen. He needed to find something, anything, to poke holes in her plan. She brought up the intricate genetic map of Leo's DNA. He scanned through the rows of adenine, guanine, cytosine, and thymine, looking for the specific insertion point, the faulty sequence. "The targeting sequence for the sgRNA is here," Clara pointed, her finger tracing a precise line on the screen. "And the corrective gene insert follows. It's designed to replace the dysfunctional protein." Julian squinted, cross-referencing the sequence with known variants. His mind, honed by years of intense medical study, worked furiously, analyzing the data, searching for discrepancies. He found none. Her plan was meticulous. Her understanding was profound. An unexpected thought pierced through his anger: *she's brilliant*. The realization was a jolt, a cold shock. He had expected arrogance, perhaps even carelessness, but certainly not this level of sharp, undeniable competence. Julian instantly crushed the thought. He pushed it deep down, smothering the dangerous spark of admiration before it could take root. Her intelligence didn't erase her actions, her lies, her betrayal.

Chapter 29: Guarded Hope